Apatinib for Advanced Biliary Carcinoma

Status Recruiting

Clinical Trial Summary

This is a phase II open-label, one-arm, single-center study of apatinib for eligible patients with advanced biliary tract carcinoma after the first-line treatment failure. A total of 55 patients is planned for enrollment. The time for enrollment is from Nov 2017 to Nov 2020, the the follow-up will be ended after Nov 2021. Patients in the study would receive oral apatinib 500-750mg qd until progression of disease.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03427242
Study type	Interventional
Source	Fudan University
Contact	Chenchen Wang, MD
Phone	+8613774232040
Email	wccnancy2003@aliyun.com
Status	Recruiting
Phase	Phase 2
Start date	November 1, 2017
Completion date	October 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01950572` - Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Completed	`NCT03101566` - Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer	Phase 2
Recruiting	`NCT05237193` - A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up
Not yet recruiting	`NCT06037655` - Chemotherapy Combined With Adebrelimab and Mecapegfilgrastim in Neoadjuvant Treatment of Potentially Resectable BTC	Phase 2
Recruiting	`NCT04584008` - Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics	N/A
Completed	`NCT00196105` - Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)	N/A
Completed	`NCT02558959` - Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer	Phase 2
Completed	`NCT02829918` - Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers	Phase 2
Completed	`NCT02784353` - Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy	N/A
Recruiting	`NCT05429203` - Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope	N/A
Recruiting	`NCT02255669` - Fully Covered SEMS Versus Partially Covered SEMS With Anti-migration System for Malignant Distal Biliary Obstruction	N/A
Completed	`NCT01731821` - Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy	Phase 3
Completed	`NCT00422409` - Endoscopic Stenting of Gastrointestinal Cancer	N/A
Terminated	`NCT02900248` - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Recruiting	`NCT03063554` - EUS BD vs ERCP TP for Pancreatic Cancer	N/A
Terminated	`NCT02615210` - Mid-Atlantic Research Group Single-Operator Cholangioscopic Assessment of Biliary Strictures	N/A
Completed	`NCT04595058` - LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent	N/A
Recruiting	`NCT04856761` - A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection
Recruiting	`NCT05615818` - Personalized Medicine for Advanced Biliary Cancer Patients	Phase 3
Terminated	`NCT00359320` - A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy	N/A